1. Home
  2. WTO vs VIVS Comparison

WTO vs VIVS Comparison

Compare WTO & VIVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WTO

UTime Limited

N/A

Current Price

$2.63

Market Cap

5.1M

Sector

Technology

ML Signal

N/A

Logo VivoSim Labs Inc.

VIVS

VivoSim Labs Inc.

N/A

Current Price

$1.48

Market Cap

4.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WTO
VIVS
Founded
2008
2007
Country
China
United States
Employees
N/A
9
Industry
Consumer Electronics/Appliances
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1M
4.9M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
WTO
VIVS
Price
$2.63
$1.48
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
12.9K
63.4K
Earning Date
08-07-2026
06-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$42.38
Revenue Next Year
N/A
$15.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.02
$1.25
52 Week High
$4.50
$5.30

Technical Indicators

Market Signals
Indicator
WTO
VIVS
Relative Strength Index (RSI) 45.80 40.09
Support Level $2.40 $1.25
Resistance Level $3.41 $2.21
Average True Range (ATR) 0.20 0.15
MACD -0.04 0.00
Stochastic Oscillator 4.76 37.10

Price Performance

Historical Comparison
WTO
VIVS

About WTO UTime Limited

UTime Ltd is engaged in the design, development, production, sales and brand operation of mobile phones, accessories and related consumer electronics. It also provides Electronics Manufacturing Services (EMS), including Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM) services, for renowned brands. The company operates in China and its products are sold globally, including Mexico, Brazil, the United States, and other emerging markets in South Asia and Africa as well as Europe. It has two in-house brands, UTime, known as its middle-to-high end label and targets middle class consumers from emerging markets; as its low- to mid-end brand, is positioned to the grassroots consumers and price-sensitive consumers in emerging markets.

About VIVS VivoSim Labs Inc.

VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.

Share on Social Networks: